Cerebrospinal fluid amyloid β1-42 levels in the mild cognitive impairment stage of Alzheimer's disease

Masahiro Maruyama, Hiroyuki Arai, Mitsunori Sugita, Haruko Tanji, Makoto Higuchi, Nobuyuki Okamura, Toshifumi Matsui, Susumu Higuchi, Sachio Matsushita, Hiroshi Yoshida, Hidetada Sasaki

Research output: Contribution to journalArticlepeer-review

88 Citations (Scopus)

Fingerprint Dive into the research topics of 'Cerebrospinal fluid amyloid β<sub>1-42</sub> levels in the mild cognitive impairment stage of Alzheimer's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences